Disclosures

Thomas Flaig, MD

Professor, Medicine-Medical Oncology and Vice Chancellor for Research, Anschutz Medical Campus, Aurora, Colorado

Received clinical research support/data safety monitoring board from Agensys, Astellas Pharma US, AstraZeneca, Bristol Myers Squibb, Genentech, Janssen Pharmaceutica Products, Merck & Co, sanofi-aventis U.S., and Seattle Genetics

Served on scientific advisory board or as a consultant or expert witness for Aurora Oncology (founder), Janssen Pharmaceutica Products, and Seattle Genetics

Was issued a patent for work done at the University of Colorado and now Aurora Oncology

William J. Gradishar, MD, FACP, FASCO

Betty Bramsen Professor of Breast Oncology and Chief, Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Received clinical research support/data safety monitoring board from Daiichi Sankyo, Genentech, Novartis, and Seattle Genetics

Served on scientific advisory board or as a consultant or expert witness for ambrx, AstraZeneca, Merck & Co, and Pfizer

Prashant Kapoor, MD, FACP

Assistant Professor of Medicine and Oncology (Division of Hematology), Mayo Clinic, Rochester, Minnesota

Served on scientific advisory board or as a consultant or expert witness for BeiGene, Pharmacyclics, X4 Pharmaceuticals, Oncopeptides, Angitia Bio, GSK, AbbVie, and Sanofi

Received research funding from Amgen, Regeneron, Bristol Myers Squibb, Loxo Pharmaceuticals, Ichnos, Karyopharm, Sanofi, AbbVie, and GSK

Shaji K. Kumar, MD

Professor of Medicine, Mayo Clinic, Rochester, Minnesota

Received clinical research support/data safety monitoring board from AbbVie, Allogene, Arcellx, Bristol Myers Squibb, Carsgen, GlaxoSmithKline, MedImmune, Oncopeptides, Roche Laboratories, and Takeda Pharmaceuticals North America

Served on scientific advisory board or as a consultant or expert witness for AbbVie, BeiGene, Bluebird, Bristol Myers Squibb, Epizyme, GlaxoSmithKline, GLH Pharma, Oncopeptides, Pfizer, Regeneron Pharmaceuticals, Roche Laboratories, sanofi-aventis US, Secura, Takeda Pharmaceuticals North America, and Trillium

Soo Park, MD

Associate Professor, Division of Hematology/Oncology, UC San Diego Moores Cancer Center,
San Diego, California

Received clinical research support/data safety monitoring board from Regeneron Pharmaceuticals

Served on scientific advisory board or as a consultant or expert witness for Regeneron Pharmaceuticals

Gregory J. Riely, MD, PhD

Vice Chair of Clinical Research, Department of Medicine, Memorial Sloan Kettering Cancer Center,
New York, New York

Received clinical research support/data safety monitoring board from Amgen, Chugai, Eli Lilly and Company, Genentech, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, Rain Therapeutics, and Takeda Pharmaceuticals North America

Served on scientific advisory board or as a consultant or expert witness for AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, and Takeda Pharmaceuticals North America

Sandy Srinivas, MD

Professor of Medicine/Oncology, Stanford University School of Medicine, Palo Alto, California

Received institutional research support from AstraZeneca Pharmaceuticals, Bayer HealthCare, Bristol Myers Squibb Company, Clovis Oncology, Eisai, Exelixis, Genentech, Merck & Co., Pfizer, and Seattle Genetics

Served on scientific advisory board or as a consultant or expert witness to AstraZeneca Pharmaceuticals, AVEO Pharmaceuticals, Bayer HealthCare, Bristol Myers Squibb Company, Eisai, Janssen Pharmaceutica Products, Merck & Co., Novartis Pharmaceuticals Corporation, and Seattle Genetics

Medical Writers:

The following medical writers reported no conflicts of interest.

Jenna Carter, PhD; Celeste L. Dixon; Anna Fanelli; Julia Fiederlein Cipriano; Joseph Cupolo, Bryna Goeking, Justine Landin, PhD; Susan London; Sarah Lynch; Victoria Kuhr, BA; Amy MacDonald, MS; Joshua Madera, MD; Margie Miller; Susan Reckling, MA; Kayci Reyer; Emily Rhodes; Amanda E. Ruffino, BA; Chris Schimpf, BS; Joshua Swore, PhD